Article Text

PDF
▼Fingolimod for multiple sclerosis
  • Relevant BNF section: BNF 8.2.4

Abstract

▼Fingolimod (Gilenya - Novartis) is a new treatment for patients with highly active relapsing-remitting multiple sclerosis. It is the first oral disease-modifying drug for the treatment of patients with multiple sclerosis. Here we assess the place of this drug.

Statistics from Altmetric.com

  • Relevant BNF section: BNF 8.2.4

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.